Review
doi: 10.4103/0301-4738.114099.
Medical management of uveitis - current trends
Affiliations
- PMID: 23803479
- PMCID: PMC3744780
- DOI: 10.4103/0301-4738.114099
Item in Clipboard
Review
Medical management of uveitis - current trends
Indian J Ophthalmol.
2013 Jun.
Abstract
Uveitis is a challenging disease to treat. Corticosteroids have been used in the treatment of uveitis for many years. Immunosuppressives are gaining momentum in recent years in the treatment of uveitis. In this article we present an overview of current treatment of uveitis and the major breakthroughs and advances in drugs and ocular drug delivery systems in the treatment of uveitis.
Conflict of interest statement
Similar articles
-
HLA-B27-associated uveitis: overview and current perspectives.Curr Opin Ophthalmol. 2003 Dec;14(6):378-83. doi: 10.1097/00055735-200312000-00010. Curr Opin Ophthalmol. 2003. PMID: 14615643 Review.
-
Editorial: Immunosuppressive treatment for uveitis.Br J Ophthalmol. 1975 Aug;59(8):395-6. doi: 10.1136/bjo.59.8.395. Br J Ophthalmol. 1975. PMID: 1203225 Free PMC article. No abstract available.
-
Road to remission: a comprehensive review of therapy in uveitis.Expert Opin Investig Drugs. 2011 Nov;20(11):1497-515. doi: 10.1517/13543784.2011.617741. Epub 2011 Sep 21. Expert Opin Investig Drugs. 2011. PMID: 21936708 Review.
-
Recent developments in the treatment of uveitis: an update.Expert Opin Investig Drugs. 2009 May;18(5):609-16. doi: 10.1517/14728220902852570. Expert Opin Investig Drugs. 2009. PMID: 19388878 Review.
-
Treatment of autoimmune uveitis.Ann N Y Acad Sci. 1993 Nov 30;696:307-18. doi: 10.1111/j.1749-6632.1993.tb17166.x. Ann N Y Acad Sci. 1993. PMID: 8109836 Review.
Cited by
-
Microemulsions as Lipid Nanosystems Loaded into Thermoresponsive In Situ Microgels for Local Ocular Delivery of Prednisolone.Pharmaceutics. 2022 Sep 19;14(9):1975. doi: 10.3390/pharmaceutics14091975. Pharmaceutics. 2022. PMID: 36145726 Free PMC article.
-
Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks.Clin Ophthalmol. 2022 Nov 15;16:3753-3762. doi: 10.2147/OPTH.S388982. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36411874 Free PMC article. Review.
-
Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.Front Immunol. 2017 Sep 25;8:1121. doi: 10.3389/fimmu.2017.01121. eCollection 2017. Front Immunol. 2017. PMID: 28993766 Free PMC article.
-
Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies.Eye (Lond). 2024 Jul;38(10):1845-1854. doi: 10.1038/s41433-024-03057-6. Epub 2024 Apr 10. Eye (Lond). 2024. PMID: 38600361 Free PMC article.
-
Development of Triamcinolone Acetonide-Loaded Microemulsion as a Prospective Ophthalmic Delivery System for Treatment of Uveitis: In Vitro and In Vivo Evaluation.Pharmaceutics. 2021 Mar 25;13(4):444. doi: 10.3390/pharmaceutics13040444. Pharmaceutics. 2021. PMID: 33805986 Free PMC article.
References
-
- Nussenblatt RB, Whitcupp SM. Fundamentals and Clinical Practice. 4th ed. Philadelphia, PA: Mosby-Elsevier; 2010. Philosophy, goals and approach to medical therapy. Uveitis; pp. 76–113.
-
- Cunningham ET, Jr, Wender JD. Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol. 2010;45:352–8. - PubMed
-
- Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513. - PubMed
-
- The loteprednol etabonate US Uveitis Study Group. Controlled Evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol. 1999;127:537–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
